𝕋𝕣𝕦𝕞𝕡'𝕤 "𝔼𝕩𝕔𝕖𝕝𝕝𝕖𝕟𝕥 ℍ𝕖𝕒𝕝𝕥𝕙" ℂ𝕝𝕒𝕚𝕞 𝕌𝕟𝕕𝕖𝕣𝕞𝕚𝕟𝕖𝕕 𝕓𝕪 𝕄𝕖𝕕𝕚𝕔𝕒𝕥𝕚𝕠𝕟𝕤 𝕒𝕟𝕕 𝔻𝕖𝕞𝕖𝕟𝕥𝕚𝕒 ℂ𝕠𝕟𝕔𝕖𝕣𝕟𝕤

𝕋𝕣𝕦𝕞𝕡’𝕤 “𝕖𝕩𝕔𝕖𝕝𝕝𝕖𝕟𝕥 𝕙𝕖𝕒𝕝𝕥𝕙” 𝕔𝕝𝕒𝕚𝕞 𝕔𝕠𝕟𝕥𝕣𝕒𝕕𝕚𝕔𝕥𝕤 𝕙𝕚𝕤 𝕣𝕖𝕝𝕚𝕒𝕟𝕔𝕖 𝕠𝕟 𝕞𝕖𝕕𝕚𝕔𝕒𝕥𝕚𝕠𝕟𝕤 𝕗𝕠𝕣 𝕔𝕒𝕣𝕕𝕚𝕠𝕧𝕒𝕤𝕔𝕦𝕝𝕒𝕣 𝕣𝕚𝕤𝕜𝕤; 𝕕𝕖𝕞𝕖𝕟𝕥𝕚𝕒-𝕝𝕚𝕜𝕖 𝕤𝕪𝕞𝕡𝕥𝕠𝕞𝕤 𝕣𝕒𝕚𝕤𝕖 𝕔𝕠𝕟𝕔𝕖𝕣𝕟𝕤 𝕒𝕓𝕠𝕦𝕥 𝕔𝕠𝕞𝕡𝕝𝕖𝕥𝕚𝕟𝕘 𝕙𝕚𝕤 𝕥𝕖𝕣𝕞.

𝗔

t inauguration, Donald Trump, at 78 is the oldest U.S. president, is portrayed in the April 2025 White House health report as being in “excellent health.” 

After reviewing his daily medication regime. 

Lets dig deep into a critical review of his existing health concerns, with a highly possible event, that could result in his inability to complete his presidency.

Yet, his reliance on multiple daily medications to manage severe cardiovascular risks starkly contradicts this claim of “excellent health.”, revealing a precarious health status. 

Additionally, observed behaviors suggesting early dementia, combined with a family history of Alzheimer’s, raise serious concerns. 

A critical worry is that these health dangers, particularly a potential cardiovascular event, could prevent Trump from completing his term ending January 2029. 

Official Health Report: A Rosy Narrative 

The April 2025 report, issued after Trump’s physical at Walter Reed and authored by Dr. Sean Barbabella, asserts robust health: 

• Physical Metrics: At 6 feet 3 inches, Trump weighs 224 pounds (down from 244 in 2020), with a BMI of 29.9, just below obesity. His cholesterol is 140 (down from 223 in 2018), and blood pressure is 128/74 mmHg (elevated but not hypertensive). Cardiac exams showed no abnormalities. 

•  Cognitive Performance: Trump scored a perfect 30/30 on the Montreal Cognitive Assessment (MoCA), suggesting no mild cognitive impairment. The report cites his “exceptional cognitive function” and “active lifestyle,” including “frequent golf victories,” as evidence of vigor. 

•  Other Notes: Scarring from a July 2024 assassination attempt, a benign polyp, diverticulosis, and minor sun-damaged skin lesions were noted. 

 Dr. Barbabella concluded Trump is “fully fit” to serve. However, the report’s credibility is questioned due to non-medical references like golf victories, with Dr. Jonathan Reiner suggesting possible bias or editorial interference. 

Daily Medications: A Contradiction to “Excellent Health” 

The claim of “excellent health” is undermined by Trump’s dependence on medications critical to preventing life-threatening conditions: 

• Rosuvastatin (Crestor): A statin to lower LDL cholesterol, with increased dosage since 2018 to reduce heart attack or stroke risk. 

•  Ezetimibe (Zetia): Added since 2020 for aggressive cholesterol control, indicating significant cardiovascular risk 

•  Aspirin (81 mg daily): Prevents blood clots, further signaling heart attack or stroke concerns. 

•  Mometasone Cream: Treats rosacea and sun-damaged skin. 

 This “intensive lipid-lowering therapy,” as noted by Dr. David Kessler, is typically for patients at high risk of cardiac events. 

Without these medications, Trump’s high cholesterol could lead to a catastrophic heart attack or stroke, directly contradicting the narrative of natural health. 

These drugs are essential to keeping him alive, exposing the fragility of his condition. 

Mental Condition and Early Dementia Symptoms 

Concerns about cognitive decline are fueled by Trump’s family history of Alzheimer’s (his father’s diagnosis) and public behavior: 

• Memory Lapses: Journalist Ramin Setoodeh (2023) reported Trump forgetting conversations and repeating stories. Fred Trump III noted similar disorientation and repetition. 

•  Language Difficulties: Slurred speech and incoherent tangents in 2024 campaign events, highlighted on X, suggest cognitive struggles. 

•  Disorientation: Confusing names (e.g., Nikki Haley for Nancy Pelosi) and referencing Barack Obama as a current opponent indicate impairment. 

•  Impaired Judgment: Endorsing debunked claims, like hydroxychloroquine for COVID-19, raises reasoning concerns.  

Over 200 health professionals in 2024 demanded detailed records, citing “observable cognitive decline.” 

Dr. Ziad Nasreddine, MoCA’s creator, noted a perfect score doesn’t rule out early dementia, especially with Trump’s cardiovascular risks increasing vascular dementia likelihood. 

Real Concern: Not Completing His Term 

A critical concern is that Trump’s cardiovascular vulnerabilities, managed by intensive medication, could lead to a debilitating or fatal heart attack or stroke, preventing him from completing his second term. 

His age, history of high cholesterol, and severe 2020 COVID-19 complications (low oxygen, lung infiltrates) heighten this risk. 

Cognitive decline could further impair his ability to handle the presidency’s demands, exacerbating health-related challenges. 

Conclusion 

The April 2025 report’s claim of “excellent health” is contradicted by Trump’s reliance on rosuvastatin, ezetimibe, aspirin, and mometasone to manage life-threatening cardiovascular risks and skin conditions. 

Observed dementia-like symptoms—memory lapses, disorientation, and language issues—suggest cognitive decline, unaddressed by basic MoCA testing. 

The real danger is that a cardiovascular event could incapacitate Trump, preventing him from serving through 2029. 

Transparency and rigorous testing are essential to assess his fitness.

𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝔅𝔯𝔲𝔠𝔢 𝔄𝔩𝔭𝔦𝔫𝔢

.